EVDI vs MYLERAN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. EVDI and MYLERAN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EVDI	MYLERAN
Rating	66/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TRABECTEDIN	BUSULFAN
Manufacturer	Apotex	Waylis Therap
Dosage forms	Injectable	Tablet
Drug class	Alkylating Drug	Alkylating Drug
Boxed warning	None	Boxed warning
Treats	Leiomyosarcoma, Liposarcoma	Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis

evdi myleran

Rating

66/100

New

Pharmacy pays

—

Type

Active ingredient

TRABECTEDIN

BUSULFAN

Manufacturer

Apotex

Waylis Therap

Dosage forms

Injectable

Tablet

Drug class

Alkylating Drug

Boxed warning

None

Boxed warning

Treats

Leiomyosarcoma, Liposarcoma

Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis

Frequently asked questions

What is the difference between Evdi and Myleran?

Evdi contains Trabectedin, while Myleran contains Busulfan — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.